B-cell and plasma-cell splicing differences: A potential role in regulated immunoglobulin RNA processing

RNA

Volumn 9, Issue 10, 2003, Pages 1264-1273

  Bruce, Shirley R ^a,b   Dingle, R W Cameron ^a   Peterson, Martha L ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cleavage polyadenylation; RNA splicing; SR proteins

Indexed keywords

ADENOSINE TRIPHOSPHATASE; COMPLEMENTARY DNA; IMMUNOGLOBULIN M; MESSENGER RNA; MESSENGER RNA PRECURSOR; POLYADENYLIC ACID; PROTEIN; RNA; SR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; DNA SEQUENCE; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PLASMA CELL; POLYADENYLATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; RNA SPLICING;

ALTERNATIVE SPLICING; ANIMALS; B-LYMPHOCYTES; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN MU-CHAINS; INTRONS; MICE; PLASMA CELLS; POLY A; POLYADENYLATION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER;

ANIMALIA;

EID: 0141520691     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: 10.1261/rna.5820103     Document Type: Article

References (52)

1. Bai, Y., Lee, D., Yu, T., and Chasin, L.A. 1999. Control of 3′ splice site choice in vivo by ASF/SF2 and hnRNP A1. Nucleic Acids Res. 27:1126-1134.
2. Barnard, D.C. and Patton, J.G. 2000. Identification and characterization of a novel serine-arginine-rich splicing regulatory protein. Mol. Cell. Biol. 20:3049-3057.
3. Bruce, S.R. and Peterson, M.L. 2001. Multiple features contribute to efficient constitutive splicing of an unusually large exon. Nucleic Acids Res. 29: 2292-2302.
4. Bruce, S.R., Kaetzel, C.S., and Peterson, M.L. 1999. Cryptic intron activation within the large exon of the mouse polymeric immunoglobulin gene: Cryptic splice sites correspond to protein domain boundaries. Nucleic Acids Res. 27: 3446-3454.
5. Caceres, J.F., Stamm, S., Helfman, D.M., and Krainer, A.R. 1994. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265: 1706-1709.
6. Calame, K.L. 2001. Plasma cells: Finding new light at the end of B cell development. Nat. Immunol. 2: 1103-1108.
7. Cartegni, L., Chew, S.L., and Krainer, A.R. 2002. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 3: 285-298.
8. Chandler, S.D., Mayeda, A., Yeakley, J.M., Krainer, A.R., and Fu, X.-D. 1997. RNA splicing specificity determined by the coordinated action of RNA recognition motifs in SR proteins. Proc. Natl. Acad. Sci. 94: 3596-3601.
9. Colwill, K., Pawson, T., Andrews, B., Prasad, J., Manley, J.L., Bell, J.C., and Duncan, P.I. 1996. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intracellular distribution. EMBO J. 15: 265-275.
10. Cowper, A.E., Caceres, J.F., Mayeda, A., and Screaton, G.R. 2001. Serine-arginine (SR) protein-like factors that antagonize authentic SR proteins and regulate alternative splicing. J. Biol. Chem. 276:48908-48914.
11. Du, K., Peng, Y., Greenbaum, L.E., Haber, B.A., and Taub, R. 1997. HRS/SRp40-mediated inclusion of the fibronectin EIIIB exon, a possible cause of increased EIIIB expression in proliferating liver. Mol. Cell. Biol. 17: 4096-4104.
12. Edwalds-Gilbert, G. and Milcarek, C. 1995. Regulation of poly(A) site use during mouse B-cell development involves a change in the binding of a general polyadenylation factor in a B-cell stage-specific manner. Mol. Cell. Biol. 15: 6420-6429
13. Edwalds-Gilbert, G., Veraldi, K.L., and Milcarek, C. 1997. Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res. 25: 2547-2561.
14. Eperon, I.C., Makarova, O.V., Mayeda, A., Munroe, S.H., Caceres, J.F., Hayward, D.G., and Krainer, A.R. 2000. Selection of alternative 5′ splice sites: Role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1. Mol. Cell. Biol. 20: 8303-8318.
15. Fu, X.-D. 1995. The superfamily of arginine/serine-rich splicing factors. RNA 1: 663-680.
16. Gamberi, C., Izaurralde, E., Beisel, C., and Mattaj, I.W. 1997. Interaction between the human nuclear cap-binding protein complex and hnRNP F. Mol. Cell. Biol. 17: 2587-2597.
17. Graveley, B.R. 2000. Sorting out the complexity of SR protein functions. RNA 6: 1197-1211.
18. Grosschedl, R. and Baltimore, D. 1985. Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell 41: 885-897.
19. Hanamura, A., Caceres, J.F., Mayeda, A., Franza Jr., B.R., and Krainer, A.R. 1998. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4:430-444.
20. Jiang, Z.H., Zhang, W.J., Rao, Y., and Wu, J.Y. 1998. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc. Natl. Acad. Sci. 16: 9155-9160.
21. Liu, H.-X., Zhang, M., and Krainer, A.R. 1998. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes & Dev. 12: 1998-2012.
22. Lou, H., Neugebauer, K.M., Gagel, R.F., and Berget, S.M. 1998. Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol. Cell. Biol. 9:4977-4985.
23. Manley, J. and Tacke, R. 1996. SR proteins and splicing control. Genes & Dev. 10: 1569-1579.
24. Martincic, K., Campbell, R., Edwalds-Gilbert, G., Souan, L., Lotze, M.T., and Milcarek, C. 1998. Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the Go to S phase transition. Proc. Natl. Acad. Sci. 95: 11095-11100.
25. Matis, S.A., Martincic, K., and Milcarek, C. 1996. B-lineage regulated polyadenylation occurs on weak poly(A) sites regardless of sequence composition at the cleavage and downstream regions. Nucleic Acids Res. 24: 4684-4692.
26. Mayeda, A. and Krainer, A.R. 1992. Regulation of alternative splicing by hnRNP A1 and splicing factor SF2. Cell 68: 365-375.
27. Milcarek, C., Suda-Hartman, M., and Croll, S.C. 1998. Changes in abundance of IgG 2a mRNA in the nucleus and cytoplasm of a murine B-lymphoma before and after fusion to a myeloma cell. Mol. Immunol. 33: 691-701.
28. Milcarek, C., Martincic, K., Chung-Ganster, L.-H., and Lutz, C.S. 2003. The snRNP-associated U1A levels change following IL-6 stimulation of human B cells. Mol. Immunol. 39: 809-814.
29. Min, H., Chan, R.C., and Black, D.L. 1995. The generally expressed hnRNP F is involved in a neural-specific pre-mRNA splicing event. Genes & Dev. 9: 2659-2671.
30. Nelson, K.J., Haimovich, J., and Perry, R.P. 1983. Characterization of productive and sterile transcripts from the immunoglobulin heavy-chain locus: Processing of μm and μs mRNA. Mol. Cell. Biol. 3: 1317-1332.
31. Peterson, M.L. 1992. Balanced efficiencies of splicing and cleavage-polyadenylation are required for μs and μm mRNA regulation. Gene Expr. 2: 319-327.
32. -. 1994a. Regulated immunoglobulin (Ig) RNA processing does not require specific cis-acting sequences: Non-Ig genes can be alternatively processed in B cells and plasma cells. Mol. Cell. Biol. 14:7891-7898.
33. -. 1994b. RNA processing and the expression of immunoglobulin genes. In Handbook of B and T lymphocytes (ed. E.C. Snow), pp. 321-342. Academic Press, San Diego, CA.
34. Peterson, M.L. and Perry, R.P. 1986. Regulated production of μm and μs mRNA requires linkage of the poly(A) addition sites and is dependent on the length of the μs-μm intron. Proc. Natl. Acad. Sci. 83: 8883-8887.
35. -. 1989. The regulated production of μm and μs mRNA is dependent on the relative efficiencies of μs poly(A) site usage and the Cμ4-to-M1 splice. Mol. Cell. Biol. 9: 726-738.
36. Peterson, M.L., Gimmi, E.R., and Perry, R.P. 1991. The developmentally regulated shift from membrane to secreted μ mRNA production is accompanied by an increase in cleavage-polyadenylation efficiency but no measurable change in splicing efficiency. Mol. Cell. Biol. 11: 2324-2327.
37. Phillips, C., Jung, S., and Gunderson, S.I. 2001. Regulation of nuclear poly(A) addition controls the expression of immunoglobulin M secretory mRNA. EMBO J. 20: 6443-6452.
38. Prasad, J., Colwill, K., Pawson, T., and Manley, J.L. 1999. The protein kinase Clk/Sty directly modulates SR protein activity: Both hyperand hypophosphorylation inhibit splicing. Mol. Cell. Biol. 19: 6991-7000.
39. Schaal, T.D. and Maniatis, T. 1999. Selection and characterization of pre-mRNA splicing enhancers: Identification of novel SR protein-specific enhancer sequences. Mol. Cell. Biol. 19: 1705-1719.
40. Schibler, U., Marcu, K.B., and Perry, R.P. 1978. The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells. Cell 15: 1495-1509.
41. Screaton, G.R., Caceres, J.F., Mayeda, A., Bell, M.V., Plebanski, M., Jackson, D.G., Bell, J.I., and Krainer, A.R. 1995. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14: 4336-4349.
42. Seipelt, R.L., Spear, B.T., Snow, E.C., and Peterson, M.L. 1998. A nonimmunoglobulin transgene and the endogenous immunoglobulin μ gene are coordinately regulated by alternative RNA processing during B-cell maturation. Mol. Cell. Biol. 18: 1042-1048.
43. Takagaki, Y., Seipelt, R.L., Peterson, M.L., and Manley, J.L. 1996. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 87: 941-952.
44. ten Dam, G.B., Zilch, C.F., Wallace, D., Wieringa, B., Beverley, P.C., Poels, L.G., and Screaton, G.R. 2000. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. J. Immunol. 164: 5287-5295.
45. Tsurushita, N., Ho, L., and Korn, L.J. 1988. Nuclear factors in B lymphoma enhance splicing of mouse membrane-bound μ mRNA in Xenopus oocytes. Science 239: 494-497.
46. van den Bosch, L., Mertens, L., Cavaloc, Y., Peterson, M., Wuytack, F., and Eggermont, J. 1996. Alternative processing of the sarco/ endoplasmic reticulum Ca2+-ATPase transcripts during muscle differentiation is a specifically regulated process. Biochem. J. 317: 647-651.
47. Veraldi, K.L., Arhin, G., Martincic, K., Chung-Ganster, L.-H., Wilusz, J., and Milcarek, C. 2001. hnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells. Mol. Cell. Biol. 21: 1228-1238.
48. Wang, J. and Manley, J.L. 1995. Overexpression of the SR proteins ASF/ SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1: 335-346.
49. Watakabe, A., Sakamoto, H., and Shimura, Y. 1991. Repositioning of an alternative exon sequence of mouse IgM pre-mRNA activates splicing of the preceding intron. Gene Expr. 1: 175-184.
50. Watakabe, A., Tanaka, K., and Shimura, Y. 1993. The role of exon sequences in splice site selection. Genes & Dev. 7: 407-418.
51. Xu, R., Teng, J., and Cooper, T.A. 1993. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13: 3660-3674,
52. Yan, D.-H., Weiss, E.A., and Nevins, J.R. 1995. Identification of an activity in B-cell extracts that selectively impairs the formation of an immunoglobulin μs poly(A) site processing complex. Mol. Cell. Biol. 15: 1901-1906.